This means the FDA has not reviewed it like an approved prescription drug for safety, effectiveness, and quality
And it's precisely why a therapy that builds new blood supply directly into damaged tissue can change the equation when nothing else has
Results consistently show major reductions in inflammatory markers (IL-6, TNF-alpha, CRP), less pain behavior in animal models, reduced swelling, and better function without the side effects of traditional anti-inflammatory drugs
Learn more Tirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist
Consider NAD+ injections or IV hydration therapy
Methods: This analysis is based on the DETECT cohort (Prehospital GFAP Measurements for Diagnosing ICH in Acute Stroke)